All stock lists
Unlock the score
AbCellera Biologics Inc. (NASDAQ:ABCL)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
12.16+0.34 (+2.88%)
Market cap
$3.94B
Insider Score
Analyst consensus
Listed since
Dec 11, 2020
Website
Insider Score
/ 100
ABCL Insider Score
AbCellera Biologics Inc. has a live Insider Score.
Scored on 4 qualifying trades from 3 insiders in the last 90 days.
ABCL Stock Insider Trading Activity
ABCL stock’s insider trading shows 5 purchases for an estimated $1.64M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days4 qualifying buys3 insiders$1.55M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hayden Michael R Director | Buy | 53,613 | $10.64 | $570.44K | 4.1% | 1,373,397 | Aug 24, 2026 | CCluster Buy | Form 4 |
| Montalbano John S. Director | Buy | 10,000 | $11.03 | $110.30K | 4.1% | 251,000 | Aug 18, 2026 | DCluster Buy | Form 4 |
| Booth Andrew CFO | Buy | 37,200 | $10.32 | $383.90K | 8.3% | 482,800 | Aug 14, 2026 | BCluster BuyCFO Buy | Form 4 |
| Hayden Michael R Director | Buy | 46,387 | $10.37 | $481.03K | 3.6% | 1,319,784 | Aug 12, 2026 | CCluster BuyFirst Buy | Form 4 |
| Hayden Michael R Director | Gift | 50,000 | — | — | 3.8% | 1,273,397 | Aug 11, 2026 | — | Form 4 |
| Booth Andrew CFO | Option exercise | 250,000 | $0.19 | $47.50K | 128% | 445,600 | Jun 3, 2026 | — | Form 4 |
| Montalbano John S. Director | Buy | 20,000 | $4.77 | $95.40K | 9.0% | 241,000 | May 14, 2026 | D | Form 4 |
| Thermopylae Holdings Ltd. Other | Buy | 38,000 | $3.44 | $130.72K | 0.1% | 56,134,097 | Feb 27, 2026 | — | Form 4 |
| Booth Andrew CFO | Buy | 42,600 | $3.42 | $145.69K | 27.8% | 195,600 | Feb 27, 2026 | BFirst BuyCFO Buy | Form 4 |
| Thermopylae Holdings Ltd. Other | Buy | 177,457 | $3.27 | $580.28K | 0.3% | 56,096,097 | Feb 26, 2026 | — | Form 4 |
| Thermopylae Holdings Ltd. Other | Gift | 225,000 | — | — | 0.4% | 55,918,640 | Dec 18, 2025 | — | Form 4 |
| Montalbano John S. Director | Buy | 50,000 | $3.57 | $178.46K | 29.2% | 221,000 | Nov 26, 2025 | CFirst Buy | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.